Advertisement

Topics

US FDA clarifies what constitutes 'minor' change to biologic production process

08:30 EDT 9 Aug 2017 | BioPharma-Reporter

Original Article: US FDA clarifies what constitutes 'minor' change to biologic production process

NEXT ARTICLE

More From BioPortfolio on "US FDA clarifies what constitutes 'minor' change to biologic production process"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...